Medical Care
Global Circadian Rhythm Sleep Disorders Drug Market Research Report 2025
- Jul 18, 25
- ID: 118981
- Pages: 80
- Figures: 71
- Views: 31
The global market for Circadian Rhythm Sleep Disorders Drug was valued at US$ 717 million in the year 2024 and is projected to reach a revised size of US$ 1074 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Circadian Rhythm Sleep Disorders (CRSDs) Drugs are medications used to manage sleep disorders caused by misalignments in a person’s internal biological clock — the circadian rhythm — which controls the sleep–wake cycle over a roughly 24-hour period.
The global Circadian Rhythm Sleep Disorders market is set for continued growth driven by increased awareness, advancements in treatment options, and technological innovations. The emphasis on personalized medicine, improved diagnostic tools, and a growing focus on sleep health and wellness are key factors contributing to market expansion. However, challenges such as regional disparities in awareness and the cost of advanced treatments remain. Ongoing research and development will play a crucial role in shaping the future of the market.
This report aims to provide a comprehensive presentation of the global market for Circadian Rhythm Sleep Disorders Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circadian Rhythm Sleep Disorders Drug.
The Circadian Rhythm Sleep Disorders Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Circadian Rhythm Sleep Disorders Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circadian Rhythm Sleep Disorders Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva Pharmaceuticals
Takeda Pharmaceutical
NBTY
Vicks (Procter & Gamble)
Natrol
Nature Made (Pharmavite)
Jameison
GNC
By-Health
Now Foods
Segment by Type
Melatonin
Ramelteon
Others
Segment by Application
Delayed Sleep Phase Syndrome (DSPS)
Advanced Sleep Phase Syndrome (ASPS)
Irregular Sleep-Wake Disorder (ISWD)
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circadian Rhythm Sleep Disorders Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Circadian Rhythm Sleep Disorders (CRSDs) Drugs are medications used to manage sleep disorders caused by misalignments in a person’s internal biological clock — the circadian rhythm — which controls the sleep–wake cycle over a roughly 24-hour period.
The global Circadian Rhythm Sleep Disorders market is set for continued growth driven by increased awareness, advancements in treatment options, and technological innovations. The emphasis on personalized medicine, improved diagnostic tools, and a growing focus on sleep health and wellness are key factors contributing to market expansion. However, challenges such as regional disparities in awareness and the cost of advanced treatments remain. Ongoing research and development will play a crucial role in shaping the future of the market.
This report aims to provide a comprehensive presentation of the global market for Circadian Rhythm Sleep Disorders Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circadian Rhythm Sleep Disorders Drug.
The Circadian Rhythm Sleep Disorders Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Circadian Rhythm Sleep Disorders Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circadian Rhythm Sleep Disorders Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva Pharmaceuticals
Takeda Pharmaceutical
NBTY
Vicks (Procter & Gamble)
Natrol
Nature Made (Pharmavite)
Jameison
GNC
By-Health
Now Foods
Segment by Type
Melatonin
Ramelteon
Others
Segment by Application
Delayed Sleep Phase Syndrome (DSPS)
Advanced Sleep Phase Syndrome (ASPS)
Irregular Sleep-Wake Disorder (ISWD)
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circadian Rhythm Sleep Disorders Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Melatonin
1.2.3 Ramelteon
1.2.4 Others
1.3 Market by Application
1.3.1 Global Circadian Rhythm Sleep Disorders Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Delayed Sleep Phase Syndrome (DSPS)
1.3.3 Advanced Sleep Phase Syndrome (ASPS)
1.3.4 Irregular Sleep-Wake Disorder (ISWD)
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circadian Rhythm Sleep Disorders Drug Market Perspective (2020-2031)
2.2 Global Circadian Rhythm Sleep Disorders Drug Growth Trends by Region
2.2.1 Global Circadian Rhythm Sleep Disorders Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Circadian Rhythm Sleep Disorders Drug Historic Market Size by Region (2020-2025)
2.2.3 Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Region (2026-2031)
2.3 Circadian Rhythm Sleep Disorders Drug Market Dynamics
2.3.1 Circadian Rhythm Sleep Disorders Drug Industry Trends
2.3.2 Circadian Rhythm Sleep Disorders Drug Market Drivers
2.3.3 Circadian Rhythm Sleep Disorders Drug Market Challenges
2.3.4 Circadian Rhythm Sleep Disorders Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circadian Rhythm Sleep Disorders Drug Players by Revenue
3.1.1 Global Top Circadian Rhythm Sleep Disorders Drug Players by Revenue (2020-2025)
3.1.2 Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Players (2020-2025)
3.2 Global Top Circadian Rhythm Sleep Disorders Drug Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Circadian Rhythm Sleep Disorders Drug Revenue
3.4 Global Circadian Rhythm Sleep Disorders Drug Market Concentration Ratio
3.4.1 Global Circadian Rhythm Sleep Disorders Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circadian Rhythm Sleep Disorders Drug Revenue in 2024
3.5 Global Key Players of Circadian Rhythm Sleep Disorders Drug Head office and Area Served
3.6 Global Key Players of Circadian Rhythm Sleep Disorders Drug, Product and Application
3.7 Global Key Players of Circadian Rhythm Sleep Disorders Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Circadian Rhythm Sleep Disorders Drug Breakdown Data by Type
4.1 Global Circadian Rhythm Sleep Disorders Drug Historic Market Size by Type (2020-2025)
4.2 Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Type (2026-2031)
5 Circadian Rhythm Sleep Disorders Drug Breakdown Data by Application
5.1 Global Circadian Rhythm Sleep Disorders Drug Historic Market Size by Application (2020-2025)
5.2 Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)
6.2 North America Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025)
6.4 North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)
7.2 Europe Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025)
7.4 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)
8.2 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)
9.2 Latin America Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025)
9.4 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)
10.2 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva Pharmaceuticals
11.1.1 Teva Pharmaceuticals Company Details
11.1.2 Teva Pharmaceuticals Business Overview
11.1.3 Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Introduction
11.1.4 Teva Pharmaceuticals Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.1.5 Teva Pharmaceuticals Recent Development
11.2 Takeda Pharmaceutical
11.2.1 Takeda Pharmaceutical Company Details
11.2.2 Takeda Pharmaceutical Business Overview
11.2.3 Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Introduction
11.2.4 Takeda Pharmaceutical Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.2.5 Takeda Pharmaceutical Recent Development
11.3 NBTY
11.3.1 NBTY Company Details
11.3.2 NBTY Business Overview
11.3.3 NBTY Circadian Rhythm Sleep Disorders Drug Introduction
11.3.4 NBTY Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.3.5 NBTY Recent Development
11.4 Vicks (Procter & Gamble)
11.4.1 Vicks (Procter & Gamble) Company Details
11.4.2 Vicks (Procter & Gamble) Business Overview
11.4.3 Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Introduction
11.4.4 Vicks (Procter & Gamble) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.4.5 Vicks (Procter & Gamble) Recent Development
11.5 Natrol
11.5.1 Natrol Company Details
11.5.2 Natrol Business Overview
11.5.3 Natrol Circadian Rhythm Sleep Disorders Drug Introduction
11.5.4 Natrol Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.5.5 Natrol Recent Development
11.6 Nature Made (Pharmavite)
11.6.1 Nature Made (Pharmavite) Company Details
11.6.2 Nature Made (Pharmavite) Business Overview
11.6.3 Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Introduction
11.6.4 Nature Made (Pharmavite) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.6.5 Nature Made (Pharmavite) Recent Development
11.7 Jameison
11.7.1 Jameison Company Details
11.7.2 Jameison Business Overview
11.7.3 Jameison Circadian Rhythm Sleep Disorders Drug Introduction
11.7.4 Jameison Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.7.5 Jameison Recent Development
11.8 GNC
11.8.1 GNC Company Details
11.8.2 GNC Business Overview
11.8.3 GNC Circadian Rhythm Sleep Disorders Drug Introduction
11.8.4 GNC Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.8.5 GNC Recent Development
11.9 By-Health
11.9.1 By-Health Company Details
11.9.2 By-Health Business Overview
11.9.3 By-Health Circadian Rhythm Sleep Disorders Drug Introduction
11.9.4 By-Health Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.9.5 By-Health Recent Development
11.10 Now Foods
11.10.1 Now Foods Company Details
11.10.2 Now Foods Business Overview
11.10.3 Now Foods Circadian Rhythm Sleep Disorders Drug Introduction
11.10.4 Now Foods Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.10.5 Now Foods Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Melatonin
1.2.3 Ramelteon
1.2.4 Others
1.3 Market by Application
1.3.1 Global Circadian Rhythm Sleep Disorders Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Delayed Sleep Phase Syndrome (DSPS)
1.3.3 Advanced Sleep Phase Syndrome (ASPS)
1.3.4 Irregular Sleep-Wake Disorder (ISWD)
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circadian Rhythm Sleep Disorders Drug Market Perspective (2020-2031)
2.2 Global Circadian Rhythm Sleep Disorders Drug Growth Trends by Region
2.2.1 Global Circadian Rhythm Sleep Disorders Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Circadian Rhythm Sleep Disorders Drug Historic Market Size by Region (2020-2025)
2.2.3 Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Region (2026-2031)
2.3 Circadian Rhythm Sleep Disorders Drug Market Dynamics
2.3.1 Circadian Rhythm Sleep Disorders Drug Industry Trends
2.3.2 Circadian Rhythm Sleep Disorders Drug Market Drivers
2.3.3 Circadian Rhythm Sleep Disorders Drug Market Challenges
2.3.4 Circadian Rhythm Sleep Disorders Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circadian Rhythm Sleep Disorders Drug Players by Revenue
3.1.1 Global Top Circadian Rhythm Sleep Disorders Drug Players by Revenue (2020-2025)
3.1.2 Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Players (2020-2025)
3.2 Global Top Circadian Rhythm Sleep Disorders Drug Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Circadian Rhythm Sleep Disorders Drug Revenue
3.4 Global Circadian Rhythm Sleep Disorders Drug Market Concentration Ratio
3.4.1 Global Circadian Rhythm Sleep Disorders Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circadian Rhythm Sleep Disorders Drug Revenue in 2024
3.5 Global Key Players of Circadian Rhythm Sleep Disorders Drug Head office and Area Served
3.6 Global Key Players of Circadian Rhythm Sleep Disorders Drug, Product and Application
3.7 Global Key Players of Circadian Rhythm Sleep Disorders Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Circadian Rhythm Sleep Disorders Drug Breakdown Data by Type
4.1 Global Circadian Rhythm Sleep Disorders Drug Historic Market Size by Type (2020-2025)
4.2 Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Type (2026-2031)
5 Circadian Rhythm Sleep Disorders Drug Breakdown Data by Application
5.1 Global Circadian Rhythm Sleep Disorders Drug Historic Market Size by Application (2020-2025)
5.2 Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)
6.2 North America Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025)
6.4 North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)
7.2 Europe Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025)
7.4 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)
8.2 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)
9.2 Latin America Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025)
9.4 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)
10.2 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva Pharmaceuticals
11.1.1 Teva Pharmaceuticals Company Details
11.1.2 Teva Pharmaceuticals Business Overview
11.1.3 Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Introduction
11.1.4 Teva Pharmaceuticals Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.1.5 Teva Pharmaceuticals Recent Development
11.2 Takeda Pharmaceutical
11.2.1 Takeda Pharmaceutical Company Details
11.2.2 Takeda Pharmaceutical Business Overview
11.2.3 Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Introduction
11.2.4 Takeda Pharmaceutical Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.2.5 Takeda Pharmaceutical Recent Development
11.3 NBTY
11.3.1 NBTY Company Details
11.3.2 NBTY Business Overview
11.3.3 NBTY Circadian Rhythm Sleep Disorders Drug Introduction
11.3.4 NBTY Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.3.5 NBTY Recent Development
11.4 Vicks (Procter & Gamble)
11.4.1 Vicks (Procter & Gamble) Company Details
11.4.2 Vicks (Procter & Gamble) Business Overview
11.4.3 Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Introduction
11.4.4 Vicks (Procter & Gamble) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.4.5 Vicks (Procter & Gamble) Recent Development
11.5 Natrol
11.5.1 Natrol Company Details
11.5.2 Natrol Business Overview
11.5.3 Natrol Circadian Rhythm Sleep Disorders Drug Introduction
11.5.4 Natrol Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.5.5 Natrol Recent Development
11.6 Nature Made (Pharmavite)
11.6.1 Nature Made (Pharmavite) Company Details
11.6.2 Nature Made (Pharmavite) Business Overview
11.6.3 Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Introduction
11.6.4 Nature Made (Pharmavite) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.6.5 Nature Made (Pharmavite) Recent Development
11.7 Jameison
11.7.1 Jameison Company Details
11.7.2 Jameison Business Overview
11.7.3 Jameison Circadian Rhythm Sleep Disorders Drug Introduction
11.7.4 Jameison Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.7.5 Jameison Recent Development
11.8 GNC
11.8.1 GNC Company Details
11.8.2 GNC Business Overview
11.8.3 GNC Circadian Rhythm Sleep Disorders Drug Introduction
11.8.4 GNC Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.8.5 GNC Recent Development
11.9 By-Health
11.9.1 By-Health Company Details
11.9.2 By-Health Business Overview
11.9.3 By-Health Circadian Rhythm Sleep Disorders Drug Introduction
11.9.4 By-Health Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.9.5 By-Health Recent Development
11.10 Now Foods
11.10.1 Now Foods Company Details
11.10.2 Now Foods Business Overview
11.10.3 Now Foods Circadian Rhythm Sleep Disorders Drug Introduction
11.10.4 Now Foods Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
11.10.5 Now Foods Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Melatonin
Table 3. Key Players of Ramelteon
Table 4. Key Players of Others
Table 5. Global Circadian Rhythm Sleep Disorders Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Circadian Rhythm Sleep Disorders Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Circadian Rhythm Sleep Disorders Drug Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Circadian Rhythm Sleep Disorders Drug Market Share by Region (2020-2025)
Table 9. Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Circadian Rhythm Sleep Disorders Drug Market Share by Region (2026-2031)
Table 11. Circadian Rhythm Sleep Disorders Drug Market Trends
Table 12. Circadian Rhythm Sleep Disorders Drug Market Drivers
Table 13. Circadian Rhythm Sleep Disorders Drug Market Challenges
Table 14. Circadian Rhythm Sleep Disorders Drug Market Restraints
Table 15. Global Circadian Rhythm Sleep Disorders Drug Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Circadian Rhythm Sleep Disorders Drug Market Share by Players (2020-2025)
Table 17. Global Top Circadian Rhythm Sleep Disorders Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circadian Rhythm Sleep Disorders Drug as of 2024)
Table 18. Ranking of Global Top Circadian Rhythm Sleep Disorders Drug Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Circadian Rhythm Sleep Disorders Drug Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Circadian Rhythm Sleep Disorders Drug, Headquarters and Area Served
Table 21. Global Key Players of Circadian Rhythm Sleep Disorders Drug, Product and Application
Table 22. Global Key Players of Circadian Rhythm Sleep Disorders Drug, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Circadian Rhythm Sleep Disorders Drug Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Type (2020-2025)
Table 26. Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Type (2026-2031)
Table 28. Global Circadian Rhythm Sleep Disorders Drug Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Application (2020-2025)
Table 30. Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Application (2026-2031)
Table 32. North America Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031) & (US$ Million)
Table 47. Teva Pharmaceuticals Company Details
Table 48. Teva Pharmaceuticals Business Overview
Table 49. Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Product
Table 50. Teva Pharmaceuticals Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 51. Teva Pharmaceuticals Recent Development
Table 52. Takeda Pharmaceutical Company Details
Table 53. Takeda Pharmaceutical Business Overview
Table 54. Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Product
Table 55. Takeda Pharmaceutical Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 56. Takeda Pharmaceutical Recent Development
Table 57. NBTY Company Details
Table 58. NBTY Business Overview
Table 59. NBTY Circadian Rhythm Sleep Disorders Drug Product
Table 60. NBTY Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 61. NBTY Recent Development
Table 62. Vicks (Procter & Gamble) Company Details
Table 63. Vicks (Procter & Gamble) Business Overview
Table 64. Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Product
Table 65. Vicks (Procter & Gamble) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 66. Vicks (Procter & Gamble) Recent Development
Table 67. Natrol Company Details
Table 68. Natrol Business Overview
Table 69. Natrol Circadian Rhythm Sleep Disorders Drug Product
Table 70. Natrol Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 71. Natrol Recent Development
Table 72. Nature Made (Pharmavite) Company Details
Table 73. Nature Made (Pharmavite) Business Overview
Table 74. Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Product
Table 75. Nature Made (Pharmavite) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 76. Nature Made (Pharmavite) Recent Development
Table 77. Jameison Company Details
Table 78. Jameison Business Overview
Table 79. Jameison Circadian Rhythm Sleep Disorders Drug Product
Table 80. Jameison Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 81. Jameison Recent Development
Table 82. GNC Company Details
Table 83. GNC Business Overview
Table 84. GNC Circadian Rhythm Sleep Disorders Drug Product
Table 85. GNC Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 86. GNC Recent Development
Table 87. By-Health Company Details
Table 88. By-Health Business Overview
Table 89. By-Health Circadian Rhythm Sleep Disorders Drug Product
Table 90. By-Health Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 91. By-Health Recent Development
Table 92. Now Foods Company Details
Table 93. Now Foods Business Overview
Table 94. Now Foods Circadian Rhythm Sleep Disorders Drug Product
Table 95. Now Foods Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 96. Now Foods Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Circadian Rhythm Sleep Disorders Drug Picture
Figure 2. Global Circadian Rhythm Sleep Disorders Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Circadian Rhythm Sleep Disorders Drug Market Share by Type: 2024 VS 2031
Figure 4. Melatonin Features
Figure 5. Ramelteon Features
Figure 6. Others Features
Figure 7. Global Circadian Rhythm Sleep Disorders Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Circadian Rhythm Sleep Disorders Drug Market Share by Application: 2024 VS 2031
Figure 9. Delayed Sleep Phase Syndrome (DSPS) Case Studies
Figure 10. Advanced Sleep Phase Syndrome (ASPS) Case Studies
Figure 11. Irregular Sleep-Wake Disorder (ISWD) Case Studies
Figure 12. Others Case Studies
Figure 13. Circadian Rhythm Sleep Disorders Drug Report Years Considered
Figure 14. Global Circadian Rhythm Sleep Disorders Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Circadian Rhythm Sleep Disorders Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Circadian Rhythm Sleep Disorders Drug Market Share by Region: 2024 VS 2031
Figure 17. Global Circadian Rhythm Sleep Disorders Drug Market Share by Players in 2024
Figure 18. Global Circadian Rhythm Sleep Disorders Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Circadian Rhythm Sleep Disorders Drug Revenue in 2024
Figure 20. North America Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Circadian Rhythm Sleep Disorders Drug Market Share by Country (2020-2031)
Figure 22. United States Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Circadian Rhythm Sleep Disorders Drug Market Share by Country (2020-2031)
Figure 26. Germany Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Ireland Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Share by Region (2020-2031)
Figure 34. China Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia & New Zealand Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Circadian Rhythm Sleep Disorders Drug Market Share by Country (2020-2031)
Figure 42. Mexico Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Share by Country (2020-2031)
Figure 46. Israel Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Teva Pharmaceuticals Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 50. Takeda Pharmaceutical Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 51. NBTY Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 52. Vicks (Procter & Gamble) Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 53. Natrol Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 54. Nature Made (Pharmavite) Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 55. Jameison Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 56. GNC Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 57. By-Health Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 58. Now Foods Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Melatonin
Table 3. Key Players of Ramelteon
Table 4. Key Players of Others
Table 5. Global Circadian Rhythm Sleep Disorders Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Circadian Rhythm Sleep Disorders Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Circadian Rhythm Sleep Disorders Drug Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Circadian Rhythm Sleep Disorders Drug Market Share by Region (2020-2025)
Table 9. Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Circadian Rhythm Sleep Disorders Drug Market Share by Region (2026-2031)
Table 11. Circadian Rhythm Sleep Disorders Drug Market Trends
Table 12. Circadian Rhythm Sleep Disorders Drug Market Drivers
Table 13. Circadian Rhythm Sleep Disorders Drug Market Challenges
Table 14. Circadian Rhythm Sleep Disorders Drug Market Restraints
Table 15. Global Circadian Rhythm Sleep Disorders Drug Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Circadian Rhythm Sleep Disorders Drug Market Share by Players (2020-2025)
Table 17. Global Top Circadian Rhythm Sleep Disorders Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circadian Rhythm Sleep Disorders Drug as of 2024)
Table 18. Ranking of Global Top Circadian Rhythm Sleep Disorders Drug Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Circadian Rhythm Sleep Disorders Drug Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Circadian Rhythm Sleep Disorders Drug, Headquarters and Area Served
Table 21. Global Key Players of Circadian Rhythm Sleep Disorders Drug, Product and Application
Table 22. Global Key Players of Circadian Rhythm Sleep Disorders Drug, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Circadian Rhythm Sleep Disorders Drug Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Type (2020-2025)
Table 26. Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Type (2026-2031)
Table 28. Global Circadian Rhythm Sleep Disorders Drug Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Application (2020-2025)
Table 30. Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Application (2026-2031)
Table 32. North America Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2026-2031) & (US$ Million)
Table 47. Teva Pharmaceuticals Company Details
Table 48. Teva Pharmaceuticals Business Overview
Table 49. Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Product
Table 50. Teva Pharmaceuticals Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 51. Teva Pharmaceuticals Recent Development
Table 52. Takeda Pharmaceutical Company Details
Table 53. Takeda Pharmaceutical Business Overview
Table 54. Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Product
Table 55. Takeda Pharmaceutical Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 56. Takeda Pharmaceutical Recent Development
Table 57. NBTY Company Details
Table 58. NBTY Business Overview
Table 59. NBTY Circadian Rhythm Sleep Disorders Drug Product
Table 60. NBTY Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 61. NBTY Recent Development
Table 62. Vicks (Procter & Gamble) Company Details
Table 63. Vicks (Procter & Gamble) Business Overview
Table 64. Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Product
Table 65. Vicks (Procter & Gamble) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 66. Vicks (Procter & Gamble) Recent Development
Table 67. Natrol Company Details
Table 68. Natrol Business Overview
Table 69. Natrol Circadian Rhythm Sleep Disorders Drug Product
Table 70. Natrol Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 71. Natrol Recent Development
Table 72. Nature Made (Pharmavite) Company Details
Table 73. Nature Made (Pharmavite) Business Overview
Table 74. Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Product
Table 75. Nature Made (Pharmavite) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 76. Nature Made (Pharmavite) Recent Development
Table 77. Jameison Company Details
Table 78. Jameison Business Overview
Table 79. Jameison Circadian Rhythm Sleep Disorders Drug Product
Table 80. Jameison Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 81. Jameison Recent Development
Table 82. GNC Company Details
Table 83. GNC Business Overview
Table 84. GNC Circadian Rhythm Sleep Disorders Drug Product
Table 85. GNC Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 86. GNC Recent Development
Table 87. By-Health Company Details
Table 88. By-Health Business Overview
Table 89. By-Health Circadian Rhythm Sleep Disorders Drug Product
Table 90. By-Health Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 91. By-Health Recent Development
Table 92. Now Foods Company Details
Table 93. Now Foods Business Overview
Table 94. Now Foods Circadian Rhythm Sleep Disorders Drug Product
Table 95. Now Foods Revenue in Circadian Rhythm Sleep Disorders Drug Business (2020-2025) & (US$ Million)
Table 96. Now Foods Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Circadian Rhythm Sleep Disorders Drug Picture
Figure 2. Global Circadian Rhythm Sleep Disorders Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Circadian Rhythm Sleep Disorders Drug Market Share by Type: 2024 VS 2031
Figure 4. Melatonin Features
Figure 5. Ramelteon Features
Figure 6. Others Features
Figure 7. Global Circadian Rhythm Sleep Disorders Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Circadian Rhythm Sleep Disorders Drug Market Share by Application: 2024 VS 2031
Figure 9. Delayed Sleep Phase Syndrome (DSPS) Case Studies
Figure 10. Advanced Sleep Phase Syndrome (ASPS) Case Studies
Figure 11. Irregular Sleep-Wake Disorder (ISWD) Case Studies
Figure 12. Others Case Studies
Figure 13. Circadian Rhythm Sleep Disorders Drug Report Years Considered
Figure 14. Global Circadian Rhythm Sleep Disorders Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Circadian Rhythm Sleep Disorders Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Circadian Rhythm Sleep Disorders Drug Market Share by Region: 2024 VS 2031
Figure 17. Global Circadian Rhythm Sleep Disorders Drug Market Share by Players in 2024
Figure 18. Global Circadian Rhythm Sleep Disorders Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Circadian Rhythm Sleep Disorders Drug Revenue in 2024
Figure 20. North America Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Circadian Rhythm Sleep Disorders Drug Market Share by Country (2020-2031)
Figure 22. United States Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Circadian Rhythm Sleep Disorders Drug Market Share by Country (2020-2031)
Figure 26. Germany Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Ireland Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Share by Region (2020-2031)
Figure 34. China Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia & New Zealand Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Circadian Rhythm Sleep Disorders Drug Market Share by Country (2020-2031)
Figure 42. Mexico Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Share by Country (2020-2031)
Figure 46. Israel Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Circadian Rhythm Sleep Disorders Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Teva Pharmaceuticals Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 50. Takeda Pharmaceutical Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 51. NBTY Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 52. Vicks (Procter & Gamble) Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 53. Natrol Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 54. Nature Made (Pharmavite) Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 55. Jameison Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 56. GNC Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 57. By-Health Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 58. Now Foods Revenue Growth Rate in Circadian Rhythm Sleep Disorders Drug Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232